Aryx Therapeutics OTC Pink Sheet Valuation

ARYX
 Stock
  

USD 0.0005  0.00  0.00%   

Do you wonder what the value of Aryx Therapeutics is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Aryx Therapeutics, is its stock price multiplied by the total number of shares outstanding, calculating Aryx Therapeutics' enterprise value requires a different approach. It uses Aryx Therapeutics' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Aryx Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Aryx Therapeutics from analyzing the firm fundamentals such as Current Valuation of 8.64 M, return on equity of (13,243) %, and Shares Owned by Institutions of 0.15 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Aryx Therapeutics Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Aryx Therapeutics's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Overvalued
Today 0.0005
Please note that Aryx Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Aryx Therapeutics is based on 3 months time horizon. Increasing Aryx Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Aryx Therapeutics I is useful when determining the fair value of the Aryx Therapeutics otc pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Aryx Therapeutics. Since Aryx Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aryx Therapeutics OTC Pink Sheet. However, Aryx Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
0.00042
Real Value
0.00
Upside
Estimating the potential upside or downside of Aryx Therapeutics I helps investors to forecast how Aryx Therapeutics otc pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aryx Therapeutics more accurately as focusing exclusively on Aryx Therapeutics' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00050.00050.0005
Details
Hype
Prediction
LowEstimated ValueHigh
0.000.00050.00
Details
Naive
Forecast
LowNext ValueHigh
0.00050.00050.0005
Details

Aryx Therapeutics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Aryx Therapeutics's current stock value. Our valuation model uses many indicators to compare Aryx Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aryx Therapeutics competition to find correlations between indicators driving Aryx Therapeutics's intrinsic value. More Info.
Aryx Therapeutics I is number one stock in price to book category among related companies. It is number one stock in price to sales category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aryx Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aryx Therapeutics' OTC Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aryx Therapeutics' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aryx Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aryx Therapeutics and how it compares across the competition.

About Aryx Therapeutics Valuation

The otc valuation mechanism determines the current worth of Aryx Therapeutics I on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Aryx Therapeutics I. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Aryx Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Aryx Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Aryx Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aryx Therapeutics. We calculate exposure to Aryx Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aryx Therapeutics's related companies.
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. ARYX THERAPEUTICS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 56 people.

Aryx Therapeutics Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Aryx Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio0.38
Enterprise Value To Ebitda-0.61
Please continue to Trending Equities. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for analysis

When running Aryx Therapeutics price analysis, check to measure Aryx Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aryx Therapeutics is operating at the current time. Most of Aryx Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aryx Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aryx Therapeutics' price. Additionally, you may evaluate how the addition of Aryx Therapeutics to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Please note, there is a significant difference between Aryx Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Aryx Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aryx Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.